31 related articles for article (PubMed ID: 6385990)
1. [The evaluation of the efficacy of efferent therapy in patients with acute and chronic kidney failure by the spectrum of blood middle-molecule fractions].
Kon'kova TA; Chudnovskaia MV; Golovanov SA
Urol Nefrol (Mosk); 1994; (4):35-7. PubMed ID: 7985299
[TBL] [Abstract][Full Text] [Related]
2. [Blood levels and biological activity of middle weight molecules in critical conditions of the body].
Beliakov NA; Vladyka AS; Malakhova MIa; Solomennikov AV; Shugaev AI
Anesteziol Reanimatol; 1987; (3):41-4. PubMed ID: 3631633
[No Abstract] [Full Text] [Related]
3. Methodology for identification of serum middle molecules.
Buzio C; Montagna G; Calderini C; Manari A; Migone L
Artif Organs; 1981; 4 Suppl():22-7. PubMed ID: 7295090
[TBL] [Abstract][Full Text] [Related]
4. Separation, isolation and amino acid composition of uremic peptides.
Shaykh M; Dubin A; Dunea G; Mamdani B; Ahmed S
Clin Physiol Biochem; 1984; 2(1):1-13. PubMed ID: 6488692
[TBL] [Abstract][Full Text] [Related]
5. Does lens intrinsic membrane protein MP19 contain a membrane-targeting signal?
Chen T; Li X; Yang Y; Erdene AG; Church RL
Mol Vis; 2003 Dec; 9():735-46. PubMed ID: 14735063
[TBL] [Abstract][Full Text] [Related]
6. [Peptides of the "middle molecule" group].
Galaktionov SG; Tseĭtin VM; Leonova VI; Nikolaĭchik VV; Mikhneva LM
Bioorg Khim; 1984 Jan; 10(1):5-17. PubMed ID: 6385990
[TBL] [Abstract][Full Text] [Related]
7. Peptidomic approaches in proteomic research.
Jürgens M; Schrader M
Curr Opin Mol Ther; 2002 Jun; 4(3):236-41. PubMed ID: 12139309
[TBL] [Abstract][Full Text] [Related]
8. The middle-molecule hypothesis 30 years after: lost and rediscovered in the universe of uremic toxicity?
Vanholder R; Van Laecke S; Glorieux G
J Nephrol; 2008; 21(2):146-60. PubMed ID: 18446708
[TBL] [Abstract][Full Text] [Related]
9. The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components.
Seebach D; Beck AK; Bierbaum DJ
Chem Biodivers; 2004 Aug; 1(8):1111-239. PubMed ID: 17191902
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal strategies for the removal of middle molecules.
Winchester JF; Audia PF
Semin Dial; 2006; 19(2):110-4. PubMed ID: 16551287
[TBL] [Abstract][Full Text] [Related]
11. Review of Growth Inhibitory Peptide as a biotherapeutic agent for tumor growth, adhesion, and metastasis.
Muehlemann M; Miller KD; Dauphinee M; Mizejewski GJ
Cancer Metastasis Rev; 2005 Sep; 24(3):441-67. PubMed ID: 16258731
[TBL] [Abstract][Full Text] [Related]
12. [A turning point in the knowledge of the structure-function-activity relations of elastin].
Alix AJ
J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
